Inventor · disambiguated record
Steffen Goletz
Also filed as: GOLETZ STEFFEN
26 granted patents·26 pending applications·165 citations·filing 2001–2023
96Inventor score
Top patents by PatentIndex Score
52 records- 0189US9845361B2Recognition molecules for the treatment and detection of tumorsGLYCOTOPE GMBH·Filed 2014·Granted Dec 19, 2017·8 cites·7 claims
- 0289US9051356B2Use of human cells of myeloid leukaemia origin for expression of antibodiesGOLETZ STEFFEN·Filed 2007·Granted Jun 9, 2015·11 cites·46 claims
- 0389US9051370B2Humanized EGFR antibodiesGOLETZ STEFFEN·Filed 2011·Granted Jun 9, 2015·9 cites·19 claims
- 0489US8741365B2Fermentation processGOLETZ STEFFEN·Filed 2009·Granted Jun 3, 2014·8 cites·10 claims
- 0587US10280230B2Use of human cells of myeloid leukemia origin for expression of antibodiesGLYCOTOPE GMBH·Filed 2015·Granted May 7, 2019·5 cites·37 claims
- 0686US8609370B2Highly active glycoproteins-process conditions and an efficient method for their productionGOLETZ STEFFEN·Filed 2005·Granted Dec 17, 2013·14 cites·10 claims
- 0786US8088357B2Tumor-specific recognition moleculesGOLETZ STEFFEN·Filed 2003·Granted Jan 3, 2012·24 cites·6 claims
- 0885US9345794B2Tumor-specific recognition moleculesGLYCOTOPE GMBH·Filed 2013·Granted May 24, 2016·5 cites·22 claims
- 0984US8617846B2Tumor-specific recognition moleculesGOLETZ STEFFEN·Filed 2011·Granted Dec 31, 2013·5 cites·22 claims
- 1083US9359439B2Fab-glycosylated antibodiesGOLETZ STEFFEN·Filed 2011·Granted Jun 7, 2016·6 cites·11 claims
- 1182US8642276B2Method for the production of an immunostimulating mucin (MUC1)GOLETZ STEFFEN·Filed 2010·Granted Feb 4, 2014·3 cites·6 claims
- 1282US7595192B2Process for the production of temperature-induced tumor cell lysates for use as immunogenic compoundsGLYCOTOPE GMBH·Filed 2003·Granted Sep 29, 2009·21 cites·39 claims
- 1381US9217038B2MUC1 antibodiesGOLETZ STEFFEN·Filed 2010·Granted Dec 22, 2015·6 cites·18 claims
- 1481US8592165B2Carbohydrate specific cellular immunity inducing microorganisms and fractions thereofGOLETZ STEFFEN·Filed 2007·Granted Nov 26, 2013·9 cites·19 claims
- 1580US9494587B2Microorganisms or fractions thereof capable of activating cellular immunity against carbohydratesGOLETZ STEFFEN·Filed 2007·Granted Nov 15, 2016·7 cites·15 claims
- 1680US8779102B2Recognition molecules for the treatment and detection of tumorsGOLETZ STEFFEN·Filed 2004·Granted Jul 15, 2014·5 cites·37 claims
- 1778US8283161B2Tumour cell lines and uses thereofGOLETZ STEFFEN·Filed 2011·Granted Oct 9, 2012·5 cites·16 claims
- 1878US8017388B2Tumour cell lines and uses thereofGLYCOTOPE GMBH·Filed 2004·Granted Sep 13, 2011·13 cites·13 claims
- 1969US9487567B2Method for the production of an immunostimulating mucin (MUC1)GLYCOTOPE GMBH·Filed 2014·Granted Nov 8, 2016·0 cites·7 claims
- 2069US2024002841A1Means and methods for modifying multiple allelesOCTAPHARMA AG·Filed 2023·Application pending·0 cites
- 2169US2023374501A1Means and methods for modifying multiple allelesOCTAPHARMA AG·Filed 2023·Application pending·0 cites
- 2266US9527899B2Recombinant human follicle-stimulating hormoneGOLETZ STEFFEN·Filed 2011·Granted Dec 27, 2016·1 cites·17 claims
- 2363US2007116704A1Method for the production of an immunostimulating mucin (muc1)GOLETZ STEFFEN·Filed 2004·Application pending·0 cites
- 2460US2019359731A1Use of human cells of myeloid leukaemia origin for expression of antibodiesGLYCOTOPE GMBH·Filed 2019·Application pending·0 cites
- 2555US11713458B2Means and methods for modifying multiple allelesOCTAPHARMA AG·Filed 2017·Granted Aug 1, 2023·0 cites·11 claims
- 2653US2016068609A1Anti-cancer treatments with anti-egfr antibodies having a low fucosylationGLYCOTOPE GMBH·Filed 2014·Application pending·0 cites
- 2751US2015118354A1Microorganisms of the species bacteroides xylanisolvensGOLETZ STEFFEN·Filed 2012·Application pending·0 cites
- 2850US2016304577A1Glycosylated glycophorin peptidesGLYCOTOPE GMBH·Filed 2014·Application pending·0 cites
- 2949US8455253B2Differentiation of MUTZ-3 cells to produce effective dendritic cellsGOLETZ STEFFEN·Filed 2002·Granted Jun 4, 2013·0 cites·13 claims
- 3046US8846344B2Process for the purification of glycoproteinsGOLETZ STEFFEN·Filed 2010·Granted Sep 30, 2014·0 cites·23 claims
- 3145US9029143B2MUTZ-3 dendritic cellsGOLETZ STEFFEN·Filed 2012·Granted May 12, 2015·0 cites·12 claims
- 3244US2004214242A1Method for the isolation of large variances of specific molecules for a target molecule from phagemid gene libraries, and a test kitNEMOD IMMUNTHERAPIE AG·Filed 2002·Application pending·0 cites
- 3343US2015166664A1Novel therapeutic treatments with anti-her2 antibodies having a low fucosylationGLYCOTOPE GMBH·Filed 2013·Application pending·0 cites
- 3442US2020087410A1Humanized anti-cd40 antibodiesGLYCOTOPE GMBH·Filed 2018·Application pending·0 cites
- 3541US2021107961A1Fusion Protein Constructs Comprising an Anti-MUC1 Antibody and IL-15GLYCOTOPE GMBH·Filed 2019·Application pending·0 cites
- 3640US2018264086A1Mammalian follicle-stimulating hormone composition with increased stabilityGLYCOTOPE GMBH·Filed 2016·Application pending·0 cites
- 3740US2015353959A1Peptides for enhancing protein expressionGLYCOTOPE GMBH·Filed 2014·Application pending·0 cites
- 3838US2012100576A1Perfusion bioreactorGOLETZ STEFFEN·Filed 2010·Application pending·0 cites
- 3938US2019343953A1Anti-cancer treatments with an anti-muc1 antibody and an erbb inhibitorGLYCOTOPE GMBH·Filed 2018·Application pending·0 cites
- 4038US2012329092A1Process for the purification of glycoproteinsGOLETZ STEFFEN·Filed 2011·Application pending·0 cites
- 4138US2017035854A1Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormoneGLYCOTOPE GMBH·Filed 2015·Application pending·0 cites
- 4237US2018230552A1Method for Detecting Nucleic Acids in Samples Containing Biological MaterialGLYCOTOPE GMBH·Filed 2015·Application pending·0 cites
- 4337US2020148785A1Pd-l1 and ta-muc1 antibodiesGLYCOTOPE GMBH·Filed 2018·Application pending·0 cites
- 4437US2020131275A1Multispecific antibody constructs binding to muc1 and cd3GLYCOTOPE GMBH·Filed 2018·Application pending·0 cites
- 4537US2012294859A1Cancer stem cell markers and uses thereofGOLETZ STEFFEN·Filed 2011·Application pending·0 cites
- 4636US2019257832A1Natural microorganisms which are naturally capable of binding toxins and/or toxin receptorsULSEMER PHILIPPE·Filed 2017·Application pending·0 cites
- 4735US10184135B2Eukaryotic expression vectors comprising regulatory elements of the globin gene clustersGLYCOTOPE GMBH·Filed 2016·Granted Jan 22, 2019·0 cites·23 claims
- 4835US9700610B2Microorganisms carrying a tumor antigenGOLETZ STEFFEN·Filed 2012·Granted Jul 11, 2017·0 cites·12 claims
- 4935US2018028680A1Glycooptimized antibody drug conjugatesGLYCOTOPE GMBH·Filed 2016·Application pending·0 cites
- 5034US2004191303A1Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseasesFiled 2001·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →